KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In Process
Ratios

CRISPR Therapeutics AG (CRSP) Preferred Shares Issued (2016)

CRISPR Therapeutics AG's Preferred Shares Issued history spans 1 years, with the latest figure at -$15.2 million for Q4 2016.

  • For Q4 2016, Preferred Shares Issued changed N/A year-over-year to -$15.2 million; the TTM value through Dec 2016 reached $38.1 million, changed N/A, while the annual FY2016 figure was $22.8 million, 0.0% changed from the prior year.
  • Preferred Shares Issued for Q4 2016 was -$15.2 million at CRISPR Therapeutics AG, down from $15.2 million in the prior quarter.
  • Across five years, Preferred Shares Issued topped out at $38.1 million in Q2 2016 and bottomed at -$15.2 million in Q4 2016.